The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)

The National Cancer Institute (NCI) is soliciting applications from institutions/organizations to maintain or establish Lead Academic Organizations (LAOs) as part of the NCI Experimental Therapeutics Clinical Trials Network (ETCTN). The ETCTN LAOs will design, develop, monitor, conduct, and analyze early phase clinical trials involving agents under regulatory sponsorship for New Investigational Drug (IND) applications held by NCI's Division of Cancer Treatment and Diagnosis (DCTD), Cancer Therapy Evaluation Program (CTEP). Key aspects of the job include: • Designing and developing early phase clinical trials • Monitoring and conducting clinical trials • Analyzing data from clinical trials • Participating in clinical trials led by other LAOs in the network • Providing oversight for all scientific, programmatic, financial, and administrative matters related to the sites participating in ETCTN trials • Providing mentorship for investigators who are in the early stages of their research careers with a focus on clinical trials • Using the ETCTN Pharmacokinetic (PK) Resource Laboratory as a central resource to incorporate PK studies within their early phase clinical trials.